News|Articles|May 27, 2025

Conference Recap: 6 Key Trials From American Thoracic Society 2025

View conference highlights from HCPLive’s coverage of the American Thoracic Society (ATS) International Conference 2025.

The American Thoracic Society’s (ATS) International Conference took place in San Francisco, California, from May 18-21, 2025. Coined as the home of pulmonary, critical care, and sleep professionals, the 4-day conference featured the latest advances in each of these spaces, including updates on key topics in asthma, chronic obstructive pulmonary disease (COPD), lung cancer, sepsis, acute respiratory distress, sleep apnea, and more.

Related to this article

September 22nd, 2026

Agusti, chair of the GOLD Board of Directors, discusses which COPD diagnostic bottleneck AI is closest to solving and more.

September 17th, 2026

Read 6 late-breaking updates from ERS Congress 2026 that clinicians managing respiratory disease should know.

September 26th, 2026

Stay updated with the latest healthcare breakthroughs, including the FDA approval of insulin efsitora alfa-gobe (Onswik).

September 24th, 2026

Manju Dawkins, MD, discusses Skin Angels, why clinicians belong in dermatology innovation, and her work to reduce injection pain and needle anxiety.

September 23rd, 2026

This preview of EADV 2026 provides a teaser of new data and interviews being highlighted at this Vienna dermatology conference.

September 22nd, 2026

The FDA-approved update adds phase 3 HYPERION data on adults diagnosed with PAH within the past year.

September 21st, 2026

Philadelphia-area PAH specialists discuss real-world patient mismatch with trial criteria, drug sequencing, and insurance access barriers.

September 21st, 2026

The sNDA for amikacin liposome inhalation suspension is supported by phase 3b ENCORE trial data, with a PDUFA date of January 28, 2027.